Novo Nordisk A/S: Securities lawsuit filed in Denmark against Novo Nordisk ... Read more

Novo Nordisk's operating profit increased by 12% in Danish kroner and by 6% at c ... Read more

Esperoct® (turoctocog alfa pegol, N8-GP) approved in the EU ... Read more

Novo Nordisk's operating profit increased by 14% in Danish kroner and by 8% at c ... Read more

Novo Nordisk A/S: Securities lawsuit filed in Denmark against Novo Nordisk ... Read more

Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more

Novo Nordisk's operating profit increased by 12% in Danish kroner and by 6% at c ... Read more

Novo Nordisk A/S - Share repurchase programme ... Read more

Record date,

Payment, B shares,

Payment, ADRs,

EASD Annual Meeting, Barcelona